142 related articles for article (PubMed ID: 12143910)
1. Lithium and valproate treatment of pathological gambling: a randomized single-blind study.
Pallanti S; Quercioli L; Sood E; Hollander E
J Clin Psychiatry; 2002 Jul; 63(7):559-64. PubMed ID: 12143910
[TBL] [Abstract][Full Text] [Related]
2. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
[TBL] [Abstract][Full Text] [Related]
3. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).
Pallanti S; DeCaria CM; Grant JE; Urpe M; Hollander E
J Gambl Stud; 2005; 21(4):431-43. PubMed ID: 16311876
[TBL] [Abstract][Full Text] [Related]
4. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
Pallanti S; Baldini Rossi N; Sood E; Hollander E
J Clin Psychiatry; 2002 Nov; 63(11):1034-9. PubMed ID: 12444818
[TBL] [Abstract][Full Text] [Related]
5. Short-term single-blind fluvoxamine treatment of pathological gambling.
Hollander E; DeCaria CM; Mari E; Wong CM; Mosovich S; Grossman R; Begaz T
Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
[TBL] [Abstract][Full Text] [Related]
6. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
McElroy SL; Nelson EB; Welge JA; Kaehler L; Keck PE
J Clin Psychiatry; 2008 Mar; 69(3):433-40. PubMed ID: 18251624
[TBL] [Abstract][Full Text] [Related]
8. The impact of comorbidity on the management of pathological gambling.
Dell'Osso B; Hollander E
CNS Spectr; 2005 Aug; 10(8):619-21. PubMed ID: 16041292
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
Grant JE; Kim SW; Hartman BK
J Clin Psychiatry; 2008 May; 69(5):783-9. PubMed ID: 18384246
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
[TBL] [Abstract][Full Text] [Related]
11. Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.
Bowden CL; Myers JE; Grossman F; Xie Y
J Clin Psychiatry; 2004 May; 65(5):707-14. PubMed ID: 15163260
[TBL] [Abstract][Full Text] [Related]
12. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.
Kim SW; Grant JE; Adson DE; Shin YC; Zaninelli R
J Clin Psychiatry; 2002 Jun; 63(6):501-7. PubMed ID: 12088161
[TBL] [Abstract][Full Text] [Related]
13. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.
Dannon PN; Lowengrub K; Gonopolski Y; Musin E; Kotler M
Clin Neuropharmacol; 2005; 28(1):6-10. PubMed ID: 15711432
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
[TBL] [Abstract][Full Text] [Related]
15. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
Kim SW; Grant JE; Adson DE; Shin YC
Biol Psychiatry; 2001 Jun; 49(11):914-21. PubMed ID: 11377409
[TBL] [Abstract][Full Text] [Related]
16. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
Grant JE; Kim SW; Odlaug BL
Biol Psychiatry; 2007 Sep; 62(6):652-7. PubMed ID: 17445781
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity of impulse control disorders in pathological gamblers.
Grant JE; Kim SW
Acta Psychiatr Scand; 2003 Sep; 108(3):203-7. PubMed ID: 12890275
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled trial of topiramate for pathological gambling.
Berlin HA; Braun A; Simeon D; Koran LM; Potenza MN; McElroy SL; Fong T; Pallanti S; Hollander E
World J Biol Psychiatry; 2013 Mar; 14(2):121-8. PubMed ID: 21486110
[TBL] [Abstract][Full Text] [Related]
20. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
Suppes T; Kroger H; Pikalov A; Loebel A
J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
